LAKE FOREST, Calif.--(BUSINESS WIRE)--STAAR Surgical Company (NASDAQ: STAA), a leading developer, manufacturer and marketer of implantable lenses and companion delivery systems for the eye, today ...
Please provide your email address to receive an email when new articles are posted on . Intraocular lens surgery was once seen as a last resort for patients interested in spectacle independence, but ...
Clear, sharp vision is a game-changer, and for those seeking an alternative to LASIK, Implantable Collamer Lens or ICL surgery offers an innovative solution. Unlike laser-based procedures, ICL ...
LAKE FOREST, Calif.--(BUSINESS WIRE)--STAAR Surgical Company (NASDAQ: STAA), a leading developer, manufacturer and marketer of implantable lenses and companion delivery systems for the eye, today ...
In March 2022, the U.S. Food and Drug Administration (FDA) granted approval of the EVO/EVO+ Visian Implantable Collamer Lens (EVO) for the correction of myopia and myopia with astigmatism. Myopia is ...
SNU Eye Clinic earns global recognition at the Guangzhou EVO ICL Summit, strengthening Seoul’s position as a leading ...
STAAR Surgical Company (NASDAQ: STAA), the global leader in phakic IOLs with the EVO family of Implantable Collamer® Lenses (EVO ICL™) for vision correction, today announced that more than 4 million ...
Carrot LASIK & Eye Center is shedding light on one of the most important but often overlooked aspects of refractive surgery—the material used in the implantable lens itself. In its latest article, EVO ...
Jimmy O. Yang Partners with STAAR Surgical to Shine a Light on Their Vision Correction Lens, EVO ICL
LAKE FOREST, Calif., Oct. 10, 2023 /PRNewswire/ -- STAAR Surgical Company (NASDAQ: STAA), a leading developer, manufacturer and marketer of implantable lenses for the eye, is proud to announce a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results